MedPath

Gastric Ultrasound in Elective Surgical Diabetic Patients

Recruiting
Conditions
Gastric Ultrasound
Elective Surgery
Diabetes Mellitus
Interventions
Device: Gastric ultrasound
Registration Number
NCT06600035
Lead Sponsor
Tanta University
Brief Summary

The aim of this study is to evaluate the role of gastric ultrasound in elective surgical diabetic patients.

Detailed Description

Aspiration of gastric contents during perioperative period is a grave complication with significant morbidity and mortality. The overall incidence of gastric content aspiration ranges between \<0.1% and 19% and aspiration pneumonia account for 9% of all anesthesia-related mortality. Mendelson described the pathophysiological mechanisms of pulmonary aspiration, which led to the development of strategies to prevent pulmonary aspiration.

Consequently, American Society of Anesthesiologists (ASA) released preoperative fasting guidelines for healthy patients undergoing elective surgery, in order to reduce gastric content volume and minimize the risk of aspiration. However, there are still many situations where the ASA fasting guidelines may be not suitable, including urgent or emergency situations and medical conditions such as diabetes mellitus.

Ultrasound is widely available and has been proven to be a reliable, bedside assessment tool for real-time evaluation of gastric contents. As diabetic patients are prone to have an inadequately empty stomach even after an adequate fasting, ultrasound can be used prior to induction for screening the fasting gastric volume (GV) of diabetic patients and see if it is more than the recommended safe limit.

As a novel point-of-care application, ultrasound sonography allows anesthesiologists to evaluate a patient's gastric content and volume at the bedside and helps guide anesthetic and airway management.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Age ≥ 18 years.
  • Both sexes.
  • Undergoing elective surgery.
Exclusion Criteria
  • American Society of Anesthesiology (ASA) physical status >III.
  • Body mass index (BMI) outside the range of 18.5-40 Kg/m2.
  • History of upper gastrointestinal disease or previous surgery on the esophagus, stomach, or upper abdomen.
  • Abnormalities of the upper gastrointestinal tract, such as gastric tumors and recent upper gastrointestinal bleeding (within the preceding 1 month).
  • Taking preoperative medicines that may delay gastric emptying (e.g., anticholinergic agents, opioids).
  • Hypothyroidism.
  • Current smoking history.
  • Pregnancy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group I - DiabeticGastric ultrasoundDiabetic patients
Group II - Non-diabeticGastric ultrasoundNon-diabetic patients
Primary Outcome Measures
NameTimeMethod
Antral cross-sectional area (CSA)Just before surgery

Cross-sectional area (CSA) will be calculated by using two perpendicular diameters-anteroposterior (AP) and craniocaudal (CC) and the formula for area of an ellipse:

CSA = (AP × CC × π)/4

Secondary Outcome Measures
NameTimeMethod
Gastric volumeJust before surgery

The gastric volume will be calculated using the previously validated formula:

GVe (gastric volume in ml) = 27.0 + \[14.6 × right - lateral CSA (cm2)\] - (1.28 × age)

Gastric volume/weightJust before surgery

Gastric volume/weight will be recorded.

Trial Locations

Locations (1)

Tanta University

🇪🇬

Tanta, El-Gharbia, Egypt

© Copyright 2025. All Rights Reserved by MedPath